NCT04232631
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
StatusTerminated
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 15 versions: 14 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Suspended trial terminated
- Sponsor's reason: Temporarily closed to enrollment as the company that provided the hyperspectral imaging camera to previous PI had new PI return the… to Study was stopped as the company that owns the hyperspectral imaging devices required their return.
- Enrollment target: estimated 700 to confirmed 157
- Primary and study completion dates changed from estimate of Sep 2026 to Nov 2, 2026
- Stopped Recruitment suspended Sponsor's reason: Temporarily closed to enrollment as the company that provided the hyperspectral imaging camera to previous PI had new PI return the devices. Since study is unfunded, currently investigating rental cost of the device.
- Eligibility criteria expanded, about 14 words
- Site details revised
- Notable Primary and study completion dates: Sep 2025 to Sep 2026v13
- Notable Primary endpoint revised
- Interventions: Snapshot NIH, Kent Imaging (Device) to SnapshotNIR, Kent Imaging (Device)
Notable Enrollment target: 200 to 700v11 Show 5 more changesShow less
- Eligibility criteria expanded, about 18 words
- Primary endpoint revised
- Interventions: Hyperview, HyperMed Imaging (Device), IntraOx Vioptix (Device), Snapshot NIH, Kent Imaging (Device) to Snapshot NIH, Kent Imaging (Device)
- Study description expanded, about 35 words
- Study arms: 1 to 2
Show 8 earlier versionsHide 8 earlier versions
- Minor Site contact updatedv10
- Notable Primary and study completion dates: Sep 2022 to Sep 2025v8
- Minor Start date: Apr 14, 2021 to Apr 28, 2021v7
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Apr 1, 2021 to Apr 14, 2021
- Site details revised
- Notable Start date: Mar 1, 2021 to Apr 1, 2021v5
- Notable Start date: Jan 1, 2021 to Mar 1, 2021v4
- Notable Start date: Nov 2, 2020 to Jan 1, 2021v3
- Notable Start date: Jul 2020 to Nov 2, 2020v2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Evaluating the effectiveness of SnapshotNIR device to measure perfusion to predict wound healing, flap survival and amputation level healing. The device will report the oxygen saturation, oxyhemoglobin and deoxyhemoglobin levels in superficial tissue.
Timeframe: Three years
Arms and interventions
patients with diabetic foot ulcers
* Patient of the investigators * Diagnosis of diabetes mellitus * One or more moderate to severe diabetic foot ulcers/infections * 18-89 years of age
Normal healthy volunteers
over 18 years of age have a foot
Devices: SnapshotNIR, Kent Imaging
Sites
1 site in 1 country
- UT Southwestern Medical Center at DallasDallas, Texas, United States